Bristol-Myers Squibb

Bristol-Myers Squibb could double patient numbers for Opdivo in kidney cancer
Fierce Pharma
Wed, 11/1/17 - 11:04 am
Bristol-Myers Squibb
Opdivo
kidney cancer
Bristol-Myers, J&J sink cash into a new $95M European biotech fund
Endpoints
Mon, 10/30/17 - 11:24 pm
JNJ
Bristol-Myers Squibb
Europe
biotech
BioGeneration Ventures
Why What’s Bad for Merck Is Good For Bristol-Myers
Barron's
Mon, 10/30/17 - 11:07 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Europe
Bristol-Myers misses 3Q profit forecasts
Yahoo/AP
Thu, 10/26/17 - 11:19 am
Bristol-Myers Squibb
earnings
Can cancer charity efforts from Roche, Bristol, AbbVie and more boost pharma's reputation?
Fierce Pharma
Mon, 10/23/17 - 09:44 am
charity
Roche
Bristol-Myers Squibb
AbbVie
cancer
reputation
Positive times for Bristol-Myers Squibb
GoinPharma
Sun, 10/22/17 - 09:47 am
Bristol-Myers Squibb
Opdivo
Yervoy
What's next for biopharma Q3 earnings
Biopharma Dive
Sat, 10/21/17 - 09:50 pm
earnings
Amgen
Bristol-Myers Squibb
Celgene
GSK
Gilead Sciences
AbbVie
Merck
Shire
Despite notable failures, cancer vaccines are poised for a leap onto the market: expert
Fierce Pharma
Wed, 10/18/17 - 09:06 am
cancer vaccines
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
That $1.25B Bristol-Myers IDO1 drug? Incyte claims a former staffer stole it
Endpoints
Sun, 10/15/17 - 01:16 pm
Bristol-Myers Squibb
IDO1
Incyte
Flexus
‘Going big’: Merck launches frontline PhIII lung cancer study for Keytruda/Yervoy combo
Endpoints
Fri, 10/6/17 - 11:41 am
Merck
lung cancer
Keytruda
Yervoy
Bristol-Myers Squibb
The 2 Surprising Reasons Exelixis, Inc. Lost 17% in September
Motley Fool
Thu, 10/5/17 - 06:14 pm
Exelixis
Bristol-Myers Squibb
Opdivo
Does Pfizer really want Bristol-Myers? Likely, says one analyst. What's it waiting for?
Fierce Pharma
Mon, 10/2/17 - 10:19 pm
Pfizer
Bristol-Myers Squibb
M&A
1 Great Biotech Stock You Have Never Heard Of
Motley Fool
Sun, 10/1/17 - 09:59 am
Halozyme Therapeutics
Roche
JNJ
Eli Lilly
Bristol-Myers Squibb
Bristol-Myers' I-O star Opdivo steps up to challenge Bayer's Stivarga in liver cancer
Fierce Pharma
Mon, 09/25/17 - 11:04 am
Bristol-Myers Squibb
Opdivo
Bayer
Stivarga
liver cancer
AbbVie pairs up another ADC cancer drug with Bristol-Myers Squibb's Opdivo
Fierce Biotech
Sat, 09/23/17 - 10:02 am
AbbVie
Bristol-Myers Squibb
Opdivo
ABBV-399
antibody-drug conjugate
non-small cell lung cancer
2 Important Dates for Big Pharma
Yahoo/GuruFocus
Wed, 09/20/17 - 11:15 pm
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
From big biopharma to biotech CEO, John Houston’s R&D journey highlights a fast-changing world
Endpoints
Wed, 09/20/17 - 09:23 am
R&D
John Houston
Big Pharma
biotech
Arvinas
GSK
Bristol-Myers Squibb
The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017
Motley Fool
Mon, 09/18/17 - 10:53 am
cancer
cancer immunotherapies
Opdivo
Bristol-Myers Squibb
Keytruda
Merck
Yervoy
Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?
Motley Fool
Sat, 09/16/17 - 12:05 pm
Halozyme
Inovalon
Teva Pharmaceutical
Unitedhealthcare Group
Roche
Bristol-Myers Squibb
Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?
Motley Fool
Sat, 09/16/17 - 12:01 pm
AbbVie
Humira
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Biogen
aducanumab

Pages